Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Adi Alkalay"'
Publikováno v:
The RAND Journal of Economics. 53:763-791
Autor:
Adi Alkalay, Gil D. Rabinovici, Hermona Soreq, Gabriel Zimmerman, Neha Agarwal, William J. Jagust, Daniela Kaufer, Bruce L. Miller
Publikováno v:
Current Alzheimer research, vol 10, iss 1
BackgroundPrevious studies have demonstrated alterations in the peripheral cholinergic system in Alzheimer's disease (AD), though results have been inconsistent and not linked to in vivo biomarkers of pathology. We examined the relationship between a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cfe2a9245ceaf656cec6849304401d3a
https://escholarship.org/uc/item/9jn2m829
https://escholarship.org/uc/item/9jn2m829
Autor:
S.J. DeArmond, J. Y. Jang, Lea T. Grinberg, Anna Karydas, Ansgar J. Furst, William J. Jagust, Mustafa Janabi, Adi Alkalay, Neha Agarwal, John Q. Trojanowski, Howard J. Rosen, Eric J. Huang, James P. O'Neil, William W. Seeley, Elizabeth C. Mormino, Matthew E. Growdon, Gil D. Rabinovici, Maria Luisa Gorno-Tempini, Bruce L. Miller, John Kornak
Objective: To compare the diagnostic performance of PET with the amyloid ligand Pittsburgh compound B (PiB-PET) to fluorodeoxyglucose (FDG-PET) in discriminating between Alzheimer disease (AD) and frontotemporal lobar degeneration (FTLD). Methods: Pa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e1439f3c91122cdc4aa729759e615f7c
https://europepmc.org/articles/PMC3236517/
https://europepmc.org/articles/PMC3236517/
Autor:
I.V. Yen, Matthew E. Growdon, Neha Agarwal, Suzanne L. Baker, Howie Rosen, Mustafa Janabi, James P. O'Neil, Gil D. Rabinovici, Adi Alkalay, William J. Jagust, Elizabeth C. Mormino, Bruce L. Miller, Michael H. Rosenbloom, M. W. Weiner, Maria Luisa Gorno-Tempini, Cindee Madison, J. Y. Jang
Publikováno v:
Neurology. 76(21)
Patients with posterior cortical atrophy (PCA) often have Alzheimer disease (AD) at autopsy, yet are cognitively and anatomically distinct from patients with clinical AD. We sought to compare the distribution of β-amyloid and glucose metabolism in P
Autor:
Maria Luisa Gorno-Tempini, William W. Seeley, Matthew E. Growdon, Neha Agarwal, William J. Jagust, Howard J. Rosen, Adi Alkalay, Bruce L. Miller, Irene V. Yen, Jung Y. Jang, Ansgar J. Furst, Suzanne L. Baker, James P. O'Neil, Cindee Madison, Gil D. Rabinovici
Publikováno v:
Alzheimer's & Dementia. 6
Autor:
Adi Alkalay, William J. Jagust, Charles DeCarli, Bruce R Reed, Helena C. Chui, Natalie L. Marchant, Gil D. Rabinovici
Publikováno v:
Alzheimer's & Dementia. 6
Autor:
Daniela Kaufer, Gabriel Zimmerman, Hermona Soreq, Gil D. Rabinovici, Bruce L. Miller, Adi Alkalay, William W. Jagust, Neha Agarwal
Publikováno v:
Alzheimer's & Dementia. 6
Background: Due to its proximity to the brain, Cerebrospinal fluid (CSF) is a perfect source to search for new biomarkers to improve early diagnosis of neurological diseases. Standardization of pre-analytical handling of the sample is important to ob
Autor:
Ansgar J. Furst, William J. Jagust, Ara H. Rostomian, Caroline A. Racine, Tyler Steed, Gil D. Rabinovici, Bruce L. Miller, Adi Alkalay
The authors investigated relationships between glucose metabolism, amyloid load, and measures of cognitive and functional impairment in Alzheimer's disease (AD). Patients meeting criteria for probable AD underwent 11 C-labeled Pittsburgh Compound-B (
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::353464a47451d1f630377f4f7eecb0eb
https://europepmc.org/articles/PMC2920373/
https://europepmc.org/articles/PMC2920373/
Publikováno v:
Expert opinion on pharmacotherapy. 9(8)
Many hypertensive patients have suboptimal control of their blood pressure. One of the most common causes is poor adherence with treatment.To identify factors associated with poorer adherence to antihypertensive treatment.The study was conducted in f